Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A human B-cell lymphoma line with a de novo multidrug resistance phenotype.

Cancer - 15 Mar 1992

Mohammad R M, Mohamed A N, KuKuruga M, Smith M R, al-Katib A

Abstract excerpt

A human diffuse large cell lymphoma line (WSU-DLCL) expressing multidrug resistance (MDR) was established from a patient with primary chemotherapy-resistant disease. This cell line has the same phenotypic features as malignant cells from the patient. The established cell line has features of a mature B-cell neoplasm with no evidence for commitment to other lineages. WSU-DLCL grows in suspension forming relatively...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antineoplastic Agents
Share to Cell Line
Share to Chromosome Aberrations

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Chromosome Disorders

Share to Drug Resistance

Share to Gene Expression

Share to Immunophenotyping

Share to Phenotype

Source

Identifiers

PMID: 1540884
DOI: 10.1002/1097-0142(19920315)69:6<1468::aid-cncr2820690626>3.0.co;2-8

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A human B-cell lymphoma line with a de novo multidrug resistance phenotype.PMID 1540884Read ↗

Multidrug resistance in hematological malignancy.Semantic proximity Read ↗

Multidrug resistance in leukemiaSemantic proximity Read ↗

Overcome Resistance in Doxorubicin-Adapted Hodgkin Lymphoma Cells With Acquired Multidrug Resistance and Improved Immunosuppressive AbilitiesSemantic proximity Read ↗

Characterization of a multidrug-resistant chronic myeloid leukemia cell line presenting multiple resistance mechanisms.Semantic proximity Read ↗

[Multidrug resistance in lymphoproliferative syndromes].Semantic proximity Read ↗

Reversal of multidrug resistance in hematological malignancies.Semantic proximity Read ↗

Multidrug resistance in the chronic lymphoproliferative disorders.Semantic proximity Read ↗

The siRNA targeted to mdr1b and mdr1a mRNAs in vivo sensitizes murine lymphosarcoma to chemotherapy.Semantic proximity Read ↗

Generation and Characterization of a Novel Multidrug Resistance Protein 2 Humanized Mouse LineSemantic proximity Read ↗

Lack of elevated drug efflux in adriamycin-resistant immunoblastic B lymphoma cells with mdr1 overexpression.Semantic proximity Read ↗

Downregulation of deoxycytidine kinase in cytarabine-resistant mantle cell lymphoma cells confers cross-resistance to nucleoside analogs gemcitabine, fludarabine and cladribine, but not to other classes of anti-lymphoma agentsSemantic proximity Read ↗

Multiple drug-resistance in variant of a human non-small cell lung carcinoma cell line, DLKP-A.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.